April 12, 2018 / 8:08 PM / 14 days ago

BRIEF-Galapagos Announces ISABELA Phase 3 Program In IPF

April 12 (Reuters) - Galapagos NV:

* GALAPAGOS ANNOUNCES ISABELA PHASE 3 PROGRAM IN IPF

* ANNOUNCES THE DESIGN OF A WORLDWIDE PHASE 3 PROGRAM, TO EVALUATE GLPG1690 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

* ISABELA PHASE 3 PROGRAM WITH GLPG1690 INTENDED TO SUPPORT NDA AND MARKET AUTHORIZATION APPLICATION SUBMISSIONS IN USA AND EU Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below